Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 324Carcinoma, Non-Small-Cell Lung 73Skin Neoplasms 66Carcinoma, Renal Cell 50Lung Neoplasms 46Breast Neoplasms 46Colorectal Neoplasms 44Neoplasms 41Carcinoma, Basal Cell 41Neoplasm Metastasis 40Squamous Cell Carcinoma of Head and Neck 36Uveal Melanoma 35Ovarian Neoplasms 34Carcinoma, Merkel Cell 32Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 27Prostatic Neoplasms 25Head and Neck Neoplasms 23Stomach Neoplasms 21Carcinoma, Hepatocellular 21Thyroid Neoplasms 20Urinary Bladder Neoplasms 19Uterine Cervical Neoplasms 18Esophageal Neoplasms 18Carcinoma, Squamous Cell 18Brain Neoplasms 17Mycosis Fungoides 16Carcinoma, Transitional Cell 16Recurrence 15

Interventions

Nerve Block 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Cancer Face × Dermatologic × 90 days × Clear all
NCT07222241 2026-05-29

Comparing Numbing Techniques in Mohs Micrographic Surgery

Abramson Cancer Center at Penn Medicine

Phase NA Recruiting
150 enrolled
Dermatologic

Skin Cancer Face

Data powered by HemOnc (CC BY 4.0) Colophon âš¡